Vasomune Therapeutics
ON - TorontoBiotechnology
Focus: Therapeutics to combat vascular dysfunction to stabilize the body as it battles disease
Vasomune Therapeutics is a life sciences company focused on Therapeutics to combat vascular dysfunction to stabilize the body as it battles disease.
Profile data last refreshed Yesterday
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AV-001
Covid19-associated ARDSClinical Trials (2)
NCT07234890Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.
Phase 2Help build intelligence for Vasomune Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.